StemCells, Inc's Milestone Clinical Trial in Pelizaeus-Merzbacher Disease Shows Evidence of Myelination Following Human Neural Stem Cell Transplantation
02 avr. 2012 06h00 HE
|
StemCells, Inc.
Trial Provides Proof-of-Concept for Cell-Based Therapy in a Myelination Disorder
Company to Host Conference Call Today to Discuss Summary Results
NEWARK, Calif., April 2, 2012 (GLOBE NEWSWIRE)...
StemCells, Inc. Announces Webcast to Discuss Pelizaeus-Merzbacher Disease Clinical Trial Results
30 mars 2012 14h15 HE
|
StemCells, Inc.
NEWARK, Calif., March 30, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it will host a conference call and webcast to discuss results from its Phase I clinical trial in...
StemCells, Inc. Grants genOway Exclusive License to Gene Insertion Technology for Genetically Engineered Mice
20 mars 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., March 20, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) and genOway (NYSE:ALGEN) announced today that they have entered into a license agreement under which StemCells has...
StemCells, Inc. Reports Fourth Quarter and Year End 2011 Financial Results and Provides Business Update
13 mars 2012 16h05 HE
|
StemCells, Inc.
NEWARK, Calif., March 13, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Announces Webcast to Discuss 2011 Financial Results and Business Update
09 mars 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., March 9, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. to Present at the 24th Annual Roth Growth OC Conference
08 mars 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., March 8, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that Rodney Young, Chief Financial Officer, will present an update on the Company's programs and...
StemCells, Inc. to Participate in Qatar International Conference on Stem Cell Science and Policy 2012
27 févr. 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Feb. 27, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that it will participate in the Qatar International Conference on Stem Cell Science and Policy, which is...
StemCells, Inc. to Present at 2012 BIO CEO Investor Conference
08 févr. 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Feb. 8, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will present an update on the Company's programs and operations at...
StemCells, Inc. Receives FDA Authorization for Age-Related Macular Degeneration Clinical Trial
02 févr. 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Feb. 2, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that the U.S. Food and Drug Administration (FDA) has authorized the initiation of a Phase I/II clinical...
StemCells, Inc. Announces Publication of Preclinical Data Demonstrating Its Human Neural Stem Cells Preserve Vision
30 janv. 2012 09h00 HE
|
StemCells, Inc.
NEWARK, Calif., Jan. 30, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced the publication of preclinical data demonstrating that its proprietary HuCNS-SC® cells (purified...